Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR3 | P29371 | 19/20 | 0.51 |
| ▸ | TACR2 | P21452 | 10/20 | 0.44 |
| ▸ | TACR1 | P25103 | 8/20 | 0.44 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3819515 | 0.90 | TACR3 (0.51) | TACR3TACR2TACR1P2RX7KCNH2 | |
| SCHEMBL931448 | 0.88 | TACR3 (0.51) | TACR3TACR2TACR1P2RX7KCNH2 | |
| SCHEMBL3818998 | 0.88 | TACR3 (0.40) | TACR3TACR2TACR1P2RX7KCNH2 | |
| SCHEMBL3813684 | 0.86 | TACR3 (0.46) | TACR3TACR2TACR1P2RX7KCNH2 | |
| SCHEMBL3815133 | 0.86 | TACR3 (0.48) | TACR3TACR2TACR1P2RX7KCNH2 | |
| SCHEMBL3815625 | 0.85 | TACR3 (0.44) | TACR3TACR2TACR1P2RX7KCNH2 | |
| SCHEMBL3814901 | 0.85 | TACR3 (0.38) | TACR3TACR2TACR1KCNH2CYP1A2 | |
| SCHEMBL3812475 | 0.84 | TACR3 (0.46) | TACR3TACR2TACR1P2RX7KCNH2 | |
| SCHEMBL3812057 | 0.83 | TACR3 (0.45) | TACR3TACR2TACR1P2RX7KCNH2 | |
| SCHEMBL3814056 | 0.83 | TACR3 (0.46) | TACR3TACR2TACR1KCNH2CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2090576-A1 | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators | Merz Pharma GmbH & Co.KGaA (DE) | 2009-08-19 | — | — | EP | claimed |
| EP-2090576-A1 | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators | Merz Pharma GmbH & Co.KGaA (DE) | 2009-08-19 | — | — | EP | disclosed |
| EP-2090576-A1 | 6-halo-pyrazolo[1,5-a]pyridines, a process for their preparation and their use as metabotropic glutamate receptor (mGluR) modulators | Merz Pharma GmbH & Co.KGaA (DE) | 2009-08-19 | — | — | EP | disclosed |
| WO-2009095253-A1 | 6-HALO-PYRAZOLO[1, 5-A]PYRIDINES, A PROCESS FOR THEIR PREPARATION AND THEIR USE AS METABOTROPIC GLUTAMATE RECEPTOR (MGLUR) MODULATORS | MERZ PHARMA GMBH & CO. KGAA (DE) | 2009-08-06 | — | — | WO | disclosed |